Boehringer Ingelheim has teamed up with the Blockchain-companies Solve.care and American health care providers in a network that connects actors in the health sector.By Christopher clover
13. June 2019BTC$8.207,00 , and 0.92%part Facebook Twitter LinkedIn xing mail
The German pharmaceutical company Boehringer Ingelheim is involved in a block chain-based health network for Diabetes patients. The "Arizona Diabetes Care, Administration Network", is the result of a cooperation with the international Health-Care platform Solve.Care and the Arizona Care Network (ACN), an Association of health care providers from the U.S. state of Arizona. This is from a press release by the 12. June, the BTC-ECHO is present.
The network will help more than 25,000 Diabetes patients in the Counties of Maricopa and Pinal in dealing with their disease. A Central role is played by the Blockchain App "Care.Wallet“ of Solve.Care. The application of networked patients, health care providers, health insurers, and employers. Patients with the Care.App, among other things, doctor appointments, reviewing your insurance benefits and medical bills to pay.
ACN tested the Care.Wallet already since the autumn of last year. According to the press release the Diabetes Care Administration Network the latest Version of the Care.Wallet of ACN is.
The Diabetes Care Administration Network will help to close the knowledge gap by providing a platform for important information about Diabetes and cardiovascular disease presents in an easily accessible manner,
said Pradeep Goel, CEO of Solve.Care. And adds:
Increasing Blockchain-affinity at Boehringer Ingelheim
This is for the Ecosystem of the health care system is invaluable, as it allows the patient a better understanding of your illness and your care needs are coordinated.
Also Graham Goodrich Boehringer Ingelheim is pleased about the additional platform, which brings patients with the medication from Boehringer Ingelheim in touch:
to We are proud of [...], patients and providers additional solutions available to keep Diabetes and cardiovascular fight diseases. Recent Changes in the recommendations for the treatment of Diabetes have given to the Management of cardiovascular risk, priority [...].
Prescription medication for the treatment of cardiovascular disease and type 2 Diabetes are among the main sources of income of Boehringer Ingelheim. The pharmaceutical group to apply, however, increasingly of the Blockchain technology. The canadian branch of the company in February announced that it, together with the IT company IBM are working on a Blockchain-based solution for more data security in clinical studies. In addition, the canadian University of British Columbia announced the establishment of a Blockchain-training program for Master graduates and post-doctoral researchers in various studies. Boehringer Ingelheim Canada is one of the sponsors of the Initiative.
The Start of the Arizona Diabetes Administration Care Network should be made in the course of this year. Should he succeed, want to investigate the parties Involved and then the opportunities for expansion in the United States and the Rest of the world.
Attention: The crypto-compass is the first digital magazine for digital currencies and Blockchain Assets. He provides you with monthly exclusive assessments, Insights and comprehensive analysis of the current situation on the Blockchain- & crypto-markets. Only now and only for as long as the stock enough: In the monthly subscription, incl. FREE Bitcoin collector coin